Andrew J Evans

Author PubWeight™ 63.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 2011 3.75
2 Validating whole slide imaging for diagnostic purposes in pathology: guideline from the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med 2013 3.39
3 Review of the current state of whole slide imaging in pathology. J Pathol Inform 2011 3.23
4 Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007 3.12
5 Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 2006 3.08
6 Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 2007 2.33
7 Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet Cytogenet 2006 2.23
8 Regulation of endocytosis via the oxygen-sensing pathway. Nat Med 2009 2.00
9 Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009 1.88
10 Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol 2009 1.77
11 Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 2008 1.53
12 Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. Eur J Cancer 2008 1.48
13 Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology 2010 1.36
14 Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. AJR Am J Roentgenol 2007 1.34
15 Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J 2005 1.30
16 Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. Radiology 2007 1.29
17 Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. Radiology 2008 1.28
18 PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade. Mod Pathol 2012 1.26
19 Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Res 2009 1.18
20 The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation. Arch Pathol Lab Med 2014 1.17
21 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 2010 1.12
22 Standardization of Gleason grading among 337 European pathologists. Histopathology 2013 1.09
23 Dominant-negative HIF-3 alpha 4 suppresses VHL-null renal cell carcinoma progression. Cell Cycle 2007 1.05
24 Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI. Med Phys 2010 1.05
25 Prostate cancer localization with multispectral MRI using cost-sensitive support vector machines and conditional random fields. IEEE Trans Image Process 2010 0.96
26 Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity. Mod Pathol 2005 0.92
27 Gleason grading: past, present and future. Histopathology 2012 0.91
28 MR-guided prostate biopsy for planning of focal salvage after radiation therapy. Radiology 2014 0.91
29 Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus. EMBO Mol Med 2010 0.90
30 Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma. Lab Invest 2007 0.89
31 Utility of whole slide imaging and virtual microscopy in prostate pathology. APMIS 2012 0.88
32 Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading. Virchows Arch 2011 0.88
33 Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia. Pathology 2013 0.88
34 Oxygen-independent degradation of HIF-alpha via bioengineered VHL tumour suppressor complex. EMBO Mol Med 2009 0.87
35 Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma. Am J Pathol 2011 0.84
36 Active surveillance for prostate cancer: the role of the pathologist. Pathology 2015 0.82
37 Amplification of anion sensing by disulfide functionalized ferrocene and ferrocene-calixarene receptors adsorbed onto gold surfaces. Dalton Trans 2010 0.82
38 Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Virchows Arch 2014 0.81
39 Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma. J Clin Pathol 2013 0.80
40 Therapy-associated effects in the prostate gland. Histopathology 2012 0.80
41 Breast carcinoma with basal phenotype: mammographic findings. AJR Am J Roentgenol 2008 0.80
42 Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis). Eur J Cancer 2009 0.79
43 Downgrading of biopsy based Gleason score in prostatectomy specimens. J Clin Pathol 2013 0.79
44 H2-driven deoxygenation of epoxides and diols to alkenes catalyzed by methyltrioxorhenium. Inorg Chem 2009 0.79
45 The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology. Breast Cancer Res Treat 2008 0.79
46 Percutaneous renal tumour biopsy. Histopathology 2014 0.78
47 Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses. Eur J Cancer 2010 0.77
48 Influence of E-cadherin expression on the mammographic appearance of invasive nonlobular breast carcinoma detected at screening. Radiology 2009 0.77
49 The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins. J Clin Pathol 2012 0.77
50 International Society of Urological Pathology (ISUP) Grading of Prostate Cancer. Am J Surg Pathol 2016 0.77
51 Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors. Can J Urol 2004 0.75
52 ATA clinical guidelines for telepathology. Telemed J E Health 2014 0.75
53 Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission. Pathology 2014 0.75
54 International Telepathology: Promises and Pitfalls. Pathobiology 2016 0.75
55 A 60-year-old woman with lymphoma and postchemotherapy thickening of the urinary bladder wall. Cytomegalovirus cystitis associated with immunosuppression. Arch Pathol Lab Med 2006 0.75
56 Implementation of Whole Slide Imaging for Clinical Purposes: Issues to Consider From the Perspective of Early Adopters. Arch Pathol Lab Med 2017 0.75
57 A tail of two axillae. Breast J 2005 0.75
58 Clinical Applications of Whole-slide Imaging in Anatomic Pathology. Adv Anat Pathol 2017 0.75
59 Pathologic quiz case: a 44-year-old woman with an incidental asymptomatic renal mass. Atypical epithelioid angiomyolipoma. Arch Pathol Lab Med 2004 0.75